ALK and neoplasm: In another study, Qin et al have shown that EML4‐ALK variant 1 can drive tumorigenesis in genetically engineered mouse models and analysis of murine tumours and primary tumour‐derived organoids contained high numbers of EML4‐ALK compartments [37].